Central Bank & Trust’s Teva Pharmaceuticals TEVA Stock Holding History

Central Bank & Trust’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-340	Closed	-$16K	–	338
2016 Q3	$16K	Hold	340	–	–	﹤0.01%	234
2016 Q2	$17K	Hold	340	–	–	﹤0.01%	235
2016 Q1	$18K	Buy	340 +100	+42%	+$5.87K	0.01%	243
2015 Q4	$16K	Hold	240	–	–	﹤0.01%	256
2015 Q3	$14K	Hold	240	–	–	﹤0.01%	277
2015 Q2	$14K	Hold	240	–	–	﹤0.01%	258
2015 Q1	$15K	Hold	240	–	–	0.01%	254
2014 Q4	$14K	Hold	240	–	–	﹤0.01%	260
2014 Q3	$13K	Buy	+240	New	+$12.7K	﹤0.01%	233

Other funds holding TEVA

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Bank of New York Mellon

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return